Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 4/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18360988 | 0.95 | KIF11 (0.49) | KIF11HSP90AA1METAP2ALDH1A1PKM | |
| SCHEMBL18361132 | 0.92 | KIF11 (0.54) | KIF11HSP90AA1METAP2ALDH1A1PKM | |
| SCHEMBL18361209 | 0.91 | KIF11 (0.43) | KIF11HSP90AA1METAP2GRM2ALDH1A1 | |
| SCHEMBL26496751 | 0.84 | KIF11 (0.50) | KIF11HSP90AA1ALDH1A1PKMPPARG | |
| SCHEMBL18374580 | 0.84 | KIF11 (0.47) | KIF11HSP90AA1ALDH1A1PKMATM | |
| SCHEMBL18361014 | 0.84 | KIF11 (0.50) | KIF11HSP90AA1ALDH1A1PKMATM | |
| SCHEMBL20902640 | 0.83 | KIF11 (0.41) | KIF11METAP2ATMMEN1NPC1 | |
| SCHEMBL24370468 | 0.83 | KIF11 (0.40) | KIF11HSP90AA1PTGDR2 | |
| SCHEMBL18361017 | 0.82 | KIF11 (0.46) | KIF11HSP90AA1ALDH1A1PKMPPARG | |
| SCHEMBL18361015 | 0.82 | KIF11 (0.49) | KIF11HSP90AA1ALDH1A1PKMPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10263196-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2019-04-16 | — | — | US | disclosed |
| EP-3138137-B1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-06-20 | — | — | EP | disclosed |
| US-20180026202-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| US-20180026202-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| WO-2017005699-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2017-01-12 | — | — | WO | disclosed |
| EP-3113239-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | cynora GmbH (DE) | 2017-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10263196-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, OXER1 | KIF11 4272/4885HSP90AA1 4841/4885METAP2 4340/4885 |
| US-20180026202-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | ORC3, OR10J3, C1R | KIF11 4250/4885HSP90AA1 4845/4885METAP2 4338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.